Bullous pemphigoid induced by m‐TOR inhibitors in renal transplant recipients

E-ISSN： 1468-3083|29|8|1626-1630

ISSN： 0926-9959

Source： JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol.29, Iss.8, 2015-08, pp. : 1626-1630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Managing risk of surgical procedures in pediatric transplant recipients taking mTOR inhibitors: What is the optimal strategy?

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

mTOR inhibitors in renal cell carcinoma

By Battelli Chiara Cho Daniel C

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 359-367

Future Medicine

Access to resources Recommend Favorite

Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 8, 2014-08 ,pp. : 847-856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rechallenge with mTOR Inhibitors in Metastatic Renal Cell Carcinoma Patients Who Progressed on Previous mTOR Inhibitor Therapy

Oncology, Vol. 85, Iss. 1, 2013-06 ,pp. : 8-13

Karger

Access to resources Recommend Favorite

Safety of mTOR inhibitor continuation in pediatric heart transplant recipients undergoing surgical procedures

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite